Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Blame Canada: Rx Reimportation To Be Subject Of Senate Hearing

Executive Summary

Legislation authorizing prescription drug reimportation from Canada will be the subject of Senate Commerce Committee hearings this year

You may also be interested in...



Imported Drugs Screening Guidelines Under Revision By Customs And FDA

FDA and the U.S. Customs Service are discussing new guidelines to screen pharmaceuticals imported through international mail

Imported Drugs Screening Guidelines Under Revision By Customs And FDA

FDA and the U.S. Customs Service are discussing new guidelines to screen pharmaceuticals imported through international mail

PBM Quality Comparisons Feature In Senate Dems’ Medicare Rx Bill

PBMs delivering a drug benefit under Medicare would be subject to quality and consumer satisfaction comparisons under Sen. Bob Graham's (D-Fla.) Medicare Rx bill

Related Content

UsernamePublicRestriction

Register

PS039727

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel